Status:
COMPLETED
Early Versus Late Administration of Insulin Glargine in T1DM During Fasting Ramadan
Lead Sponsor:
King Abdullah International Medical Research Center
Conditions:
Type1diabetes
Fasting
Eligibility:
All Genders
14+ years
Phase:
NA
Brief Summary
To compare different timing of insulin Glargine administration (early-6 pm versus standard bedtime-10 pm) as part of standard of care in patients with type1 diabetes who wish to fast the month of Rama...
Detailed Description
The investigators aim to compare the effectiveness and safety of two management strategies currently used in basal insulin adjustment for treatment of Type1 diabetes (T1DM) during fasting the holy mon...
Eligibility Criteria
Inclusion
- DM type 1
- Age \> 14 years
- Diagnosis of type 1 DM of more than 6 months.
- Committed to do SMBG
Exclusion
- Renal and hepatic impairment
- Adrenal insufficiency
- Pregnancy
- Alcohol consumption
- Any diagnosed psychiatric disease
Key Trial Info
Start Date :
February 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
185 Patients enrolled
Trial Details
Trial ID
NCT04383990
Start Date
February 28 2020
End Date
November 30 2020
Last Update
April 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KingAbullahIMRC
Jeddah, Saudi Arabia